Immuno Oncology Market by 2022- A Global Forecast
World’s one of the biggest and liable market research resource, Research and Markets recently published Immuno-Oncology Market, By Type and
Read moreroche
CDSCO Issues Alert on Using Avastin for AMD
Indian regulatory authority Central Drugs Standards Control Organization (CDSCO) released an alert on 21st Jan 2015 informing state and local
Read moreRoche initiates its first clinical trial for Down Syndrome
BASEL, Switzerland and NUTLEY, NJ: Roche has announced the commencement of its first Phase 1 clinical trial to evaluate the
Read moreUS FDA approves Vemurafenib , a Melanoma Drug
The United States Food and Drug Administration has approved vemurafenib (Zelboraf), a drug designed to treat patients with metastatic melanoma.
Read moreRoche’s melanoma treatment drug Zelboraf receives FDA Approval
WASHINGTON (AP) — The United States Food and Drug Administration has approved the first and one-of-a-kind drug manufactured by Roche
Read moreFDA approval of Regeneron’s Eylea delayed by 3 months
TARRYTOWN, N.Y. (AP) — Earlier on Tuesday, Regeneron Pharmaceuticals Inc. announced that FDA review of the company’s experimental eye drug,
Read moreRoche, Daiichi expect early FDA approval for Melanoma Drug Vemurafenib
Information gathered from close sources reveal that the US regulatory agency might approve an oral BRAF inhibitor vemurafenib jointly developed
Read moreRoche returned the financial aid offered to keep the Florence plant open
FLORENCE, S.C. (AP) — Roche has returned to the state the financial aid offered to keep the company’s Florence plant
Read more